EDGAR Filing Documents for 0001626199-21-000068

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001626199-21-000068

Filing Date

2021-05-14

Accepted

2021-05-13 17:52:58

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	s-3_2021shelf.htm	S-3	333358
2	EX-4.3	alpn-ex43_2021shelf.htm	EX-4.3	425611
3	EX-5.1	alpn-ex51_2021shelf.htm	EX-5.1	26259
4	EX-23.1	alpn-ex231_2021shelf.htm	EX-23.1	2541
5		image_01.jpg	GRAPHIC	7526
6		image_12.jpg	GRAPHIC	71812
	Complete submission text file	0001626199-21-000068.txt		896236

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102

Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545

ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)